Prothioconazole

ADVERTISEMENT

Identification

Molecular formula
C15H17Cl2N3O2S
CAS Number
178928-70-6
IUPAC Name
ethyl N-[4-[[2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methylsulfanyl]phenyl]carbamate
Molecular Weight
402.29g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.3400g/cm3
Appearance
over time.
Synonyms
Tubulozole
Interesting facts

Interesting Facts About Ethyl N-[4-[[2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methylsulfanyl]phenyl]carbamate

This remarkable compound represents a complex class of chemical entities known for their biological activity. Here are some intriguing insights:

  • Diverse Applications: Ethyl N-[4-[[2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methylsulfanyl]phenyl]carbamate is frequently explored in pharmaceutical research. Its structure suggests potential use in antimicrobial or antiparasitic therapies.
  • Complex Structure: The compound features a dioxolane ring combined with an imidazole moiety, which is crucial in many biomolecules. This structural complexity allows for unique interactions at the molecular level.
  • Chlorinated Phenyl Groups: The inclusion of chlorinated phenyl groups not only enhances the molecular stability but also increases the lipophilicity, potentially improving bioavailability in pharmacological contexts.
  • Sulfanyl Group Significance: The sulfur atom contributes to the compound's reactivity, making it a focal point for chemical transformations and the synthesis of derivative compounds.
  • Research Frontiers: Researchers are particularly interested in examining how such compounds can lead to the development of new drugs by modifying parts of its structure to optimize performance against various diseases.

To sum up, ethyl N-[4-[[2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methylsulfanyl]phenyl]carbamate embodies the intricate dance between structure and function in medicinal chemistry, highlighting the importance of chemical diversity in exploring and improving therapeutic agents.

ADVERTISEMENT